Resistance of Staphylococcus aureus Recovered from Infected Foreign Body In Vivo to Killing by Antimicrobials by Chuard, Christian et al.
110 1991;163 (June) Concise Communications 1369
results of the present study indicate that this mechanism of
entrycouldalsooperatein thepathogenesis ofHib meningitis.
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Becausepersistence of infectionsassociatedwith prostheticmaterial despite the use ofappro-
priate antibioticsis a majorclinicalproblem, the antimicrobialsusceptibility of bacteria respon-
sible for a chronic subcutaneous tissue cage infectionin rat was investigated ex vivo. Three to
6 weeks after the initiation of infection,suspensions of twostrains of Staphylococcus aureus re-
covered from the foreign body surface and surrounding fluid wereexposed to either oxacillin,
vancomycin, fleroxacin, gentamicin, or rifampin. The MBCsof these bacteria were markedly
elevated, in most cases 128 to >256 times higher than the MBC of batch culture S. aureus in
either logarithmicor stationary phase. Kinetic studies showed the bacteria did not growwhen
incubated for 2 h in Mueller-Hinton broth, possibly reflecting dormancy. Their killing wasslow
and incompleteby all antibioticsat >8 times their MIC. These data providedirect evidence of
a decreasedsusceptibility of S. aureus to the killingeffectof antimicrobials during chronicfor-
eign body infections in vivo.
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Infection is a majorcomplication of implanted devices. Pa-
tients frequently donotrespond to highdoses ofantimicrobial
agents evenif administered for prolonged periods, and for-
eign bodies usually must be removed to achieve cure. It is
known that susceptibility to antibiotics may be profoundly
affected bygrowth ofmicroorganisms nearbiomaterials. Thus
vancomycin, testedin a system mimicking infection ofa peri-
tonealdialysis catheter, wasunableto decreasethe viability
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of a population of biofilm-enclosed Staphylococcus epider-
midis [1]. Similarly, a significant survival of S. epidermidis
adherent on steelwasshown whenthe bacteriawereexposed
to a concentration of tobramycin 20-200 times higher than
the MBC that hadbeen measuredfor microorganisms in so-
lution[2]. Othershave reportedsimilarresultswithPseudo-
monas aeruginosa [3]. However, these in vitro models are
characterized by an artificial environment in whichbacteria
grow for a short time in the absence of host factors under
selected, not necessarily physiologic, conditions.
Here we used an experimental modelof chronic subcuta-
neoustissuecageinfection in rats [4] to explore the suscepti-
bilityofsuspensions ofStaphylococcusaureus recovered from
the foreign body surfaceand surrounding fluid to the killing
effect of various antistaphylococcal agents.
Materials and Methods
Bacterial strains andantimicrobial agents. Theselected S.aureus
strains120andMRGR3 werebloodstream clinicalisolatesfrompa-
tients with intravenous catheter infections. Both were penicillin-
resistant, and MRGR3 was methicillin- and gentamicin-resistant.
Standard reference preparations ofallantibiotics wereobtained from
their respective manufacturers.
Animal model. Polytetrafluoroethylene multiperforated tissue
cages (length, 32 mm; diameter, 10 mm) containing three poly-
methylmethacrylate coverslips (7 x 7 mm) were implanted sub-
cutaneously into the flank of Wistar rats. At 3-6 weeks after
implantation, the fluid thathadaccumulated in thecageswasinocu-
latedwith 1 x lOS to 1 X 106 cfuofS. aureus 120or MRGR3. Two
weeks later,a sustained and stableinfection >1 x lOS cfu/ml of tis-
sue cage fluid (mean, 1 X 107 to 1 X 108 cfu/ml) wasobtainedin
>90% of cages [4].
Isolation ofbacteria fromtissuecagefluidandcoverslipsfor sus-
ceptibility testing. Three to 6 weeks after infection, 0.1 ml of tis-
sue cage fluid wascollected. It wascentrifuged and the pellet was
resuspended in PBS(GmCO, Paisley, UK)with0.1%TritonX-100
(Merck, Darmstadt, FRG) for5 min to disrupthostcells. Afterwash-
ing,bacteriaweresonicated for 1minat 60 W (model 2200;Brand-
son Ultrasoncis, Branbury, CT) to avoid clumping andthenfurther
diluted appropriately. In control experiments, the procedure was
harmless for bacteria regarding their ability to multiply and their
susceptibility to antibiotics. Clumping, monitored by microscopy,
was very low.
Bacteriadirectlyadherentto coverslips werealsostudied. Cover-
slips were rinsed three times in PBS by gentle agitation, then ex-
posed to bovine trypsin (Serva, New York) 6 units/ml in PBS for
20 min, and sonicated for 1 min at 60 W; this methodwas shown
microscopically to efficiently detach surface-bound S. aureus. De-
tachedbacteriawerewashed and declumped. Controls proved this
procedure did not affect microorganisms. The numberof adherent
bacteria recovered from three coverslips was 5-10 times less than
that recovered from 0.1 ml of simultaneously collected tissuecage
fluid; therefore notall susceptibility testsappliedto tissuecagefluid
bacteria were possible with coverslip bacteria as the final inocula
in the latter were sometimes too low.
Determination of MBCand MIC by broth macrodilution. The
broth macrodilution method recommended by the National Com-
mitteefor Clinical LaboratoryStandards [5]wasstrictlyappliedto
determine the MIC and MBC (>99.9% killing) of oxacillin,van-
comycin, fleroxacin, gentamicin, andrifampin forS. aureus 120and
vancomycin, fleroxacin, andrifampin forS. aureus MRGR3. Tissue
cage fluid bacteria were compared with logarithmic- (3 h) and
stationary-phase (18-20h) culturesgrownin Mueller-Hinton broth
(MHB; Difco, Detroit), designated in vitro bacteria. The final in-
oculumwas4 x lOS to 2 x 1()6 cfu/mlforbothexvivoandin vitro
microorganisms. Carryover problems weresolved atupto 256/Lg/ml
withoxacillin, fleroxacin, and gentamicin and at 2.56 /Lg/ml for ri-
fampin. Coverslip-adherent bacteria could not be studied by this
method.
For S. aureus MRGR3, the MIC and MBCof vancomycin were
alsomeasured after incubation for 20 h of batchculturestationary-
phase bacteria in fibronectin (25 /Lg/ml).
Determination of MIC and MBC by agardilution. MICs and
MBCsweredetermined entirelyonsolidmediausinga{3-lactamase
neutralization procedure for oxacillin on S. aureus 120and a mem-
brane transfer technique for vancomycin on S. aureus MRGR3.
In the {3-lactamase neutralization procedure [6, 7], the inoculum
isplated onoxacillin-containing Mueller-Hinton agar(MHA; Difco),
a thin agaroverlay is placedon the bacteria, the oxacillin is inacti-
vatedwitha penicillinase solution (penase concentrate; Difco) after
determination of the MIC at 24 h, and the MBCis read after 48 h
of further incubation. Penase concentrate (1 ml) wasfound to inac-
tivate 128/Lg/ml oxacillin in20mlofMHA. Theinoculum was0.1 ml
of a solution containing 2 x lOS to 4 X 105 cfu/ml.
Themembrane transfer technique wasderived fromsimilarproce-
dures previously reported [8, 9]. An inoculum (50 /Ll) of 6 X 10"
to 1 X 106 cfu/ml wasplated on 4.7-cm-diameter, 0,45-/Lm pore-
sizecellulose filters (Millipore, Bedford, MA)lyingon MHAplates
containing vancomycin. After24h ofincubation, theMICwasread;
filters were subsequently transferred three times for 60 min onto
MHAplateswithoutantibiotic to eliminate vancomycin and finally
incubated on MHA for 48 h for MBCdetermination. Vancomycin
concentrations ~256 /Lg/ml couldbe reliably washed away withthis
method.
Parts of colonies originating from bacteria that had survived an
exposure to 256/Lg/ml vancomycin wereremoved frommembranes
when the MBCwas read. They wereused in a suspension of 5 X
lOS cfu/ml, which was immediately plated on membranes and
retested for MBC.
Killing andgrowth kinetic studies. Bacterial kinetics werestud-
iedby growth andtime-kill curves. Experiments weredonein con-
stantly agitated glasstubescontaining 10mlofMHB. Samples were
platedon MHAwitha spiralplater(SpiralSystem, Cincinnati) and
plates werereadafter48h incubation. Oxacillin, vancomycin, flerox-
acin, andgentamicin weretestedat 8timestheirMIC; forrifampin,
theconcentration was200timesthe MICto approximate the tissue
levels measured during treatment in humans. The limit for detec-
tion of viablebacteriawas 1.3loglO cfu/mlfor the first fourantibi-
otics and 2.3 loglO cfu/ml for rifampin (solution diluted to avoid
carryover). Allplateswithoutvisiblegrowth wereconsidered to be
at the detection limit.
Tissue cage fluid and in vitro bacteriawere exposed to each an-
timicrobial agent (inoculum, 1 X 105 to 3 X lOS cfu/ml for S.
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aureus 120and 1 X 106 to 3 X 106 cfu/mlfor S. aureus MRGR3).
Susceptibility of coverslip bacteria wasassessedwith oxacillin for
S. aureus 120 and vancomycin for S. aureus MRGR3 (inoculum,
2 X l()4 to 5 X l()4 cfu/ml).
Tissuecage fluidbacteria were also studied after they had been
preincubated in MHBat 3rC for4 h beforeexposure to antibiotics
(S. aureus 120 with oxacillin and S. aureus MRGR3 with van-
comycin).
Finally, a stationary-phase batchcultureof S. aureus MRGR3 that
wasgrownin broth containingfibronectin (25 Ilg/ml) for 20 h was
tested with vancomycin.
Statistics. For time-kill curves, theWilcoxon testforpairedrank-
able scores(two-tailed) wasused to compareat each time point the
differences in mean count decreases betweenthe three conditions
tested for all antibiotics on both strains.
Results
MICs. No significant difference between MICsagainstin
vitro (logarithmic- and stationary-phase) and ex vivo (tissue
cagefluid and coverslips) bacteriawasobserved. Brothmac-
rodilution and agar dilution methods yielded comparable
results (table 1).
MBCs. For in vitro bacteria, the MBC-to-MIC ratio was
1-2:1 forall antibiotics testedexceptrifampin, whichwasnot
bactericidal against logarithmic- and stationary-phase S.
aureus 120and stationary-phase S. aureus MRGR3. Except
for rifampinwith S. aureusMRGR3, there wasperfect con-
cordancebetweentheMBCsforexponential culturesand 18-
to 20-h cultures.
The difference between in vitro bacteria and bacteria as-
sociatedwith the foreign body wasstriking,witha MBC-to-
MICratio >128-256:1 in all conditions for the latter. Similar
resultswereobtainedfor bacteria recovered from tissuecage
fluid and coverslips.
The agar dilutionmethod, whichis notprone to artifactual
results(falsely elevated MBC)occasionally linkedto the ini-
tial broth incubation phase of classicprocedures, confirmed
the resultsobtainedwiththebrothmacrodilution method(ta-
ble 1).
Daughter cells originating from tissue cage fluid bacteria
that survivedexposure to a high concentration of antibiotic
had the same MBC values as in vitro bacteria.
Preincubation of stationary-phase batchculturebacteriain
fibronectin did not change their MBC.
Kineticstudies. Withbacteria in logarithmic phase,a de-
creaseof viablecounts of more than 3 10glO (mean,4.22; SD,
0.61; range, 3.37-5.03) after 24 h, that is, bactericidal activ-
ity,wasobservedin all casesexceptfor rifampinonS. aureus
120(mean, 1.68). This decrease is underestimated since the
detectionlevelwasreachedin mostcases. The 99.9% killing
levelwas usually seen 8 h after antibioticexposure. Control
populations grown without antimicrobial agents showed a
mean increaseof 1.38 ± 0.22 10glO withinthe first2 h of in-
cubation.
Table 1. MIC and MBC (ug/ml) of antimicrobial agents studied against Staphylococcus aureus strains 120 and MRGR3.
MIC MBC
Ex vivo* Ex vivo
In vitro, In vitro
logarithmic/ Tissue Tissue
stationary t cage fluid Coverslips Logarithmic Stationary cage fluid Coverslips
S. aureus120
Broth rnacrodilution
Oxacillin 0.6 0.3 NO 0.8 0.7 >256 NO
Vancomycin 1 1 NO 1.5 1 >256 NO
Fleroxacin 0.9 0.9 NO 1 1.2 >256 NO
Gentamicin 1.4 1 NO 1.5 1.3 ~256 NO
Rifampin 0.02 0.01 NO >2.56 >2.56 >2.56 NO
Agar dilution
Oxacillin 0.25 0.25 0.5 0.75 0.75 >128 >128
S. aureus MRGR3
Broth macrodilution
Vancomycin 0.9 1.4 NO 2 1.9 >256 NO
Fleroxacin 0.7 1.1 NO 1.1 1 256 NO
Rifampin 0.01 0.01 NO 0.02 >2.56 >2.56 NO
Agar dilution
Vancomycin 1.1 1.6 1.6 1.5 1.5 >200 >200
NOTE. MICs and MBCs were determined by classic broth macrodilution and by ~-Iactamase inhibition or a membrane transfer agar dilution technique. Results are mean
of ~3 determinations. NO = not done.
t Identical results were obtained with in vitro cultures in logarithmic and stationary phases.
:j:Suspensions of bacteria obtained from foreign body surface (coverslips) and surrounding fluid were directly tested with antimicrobial.
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The killing was slightly but significantly (P = .028) less
for stationary-phase bacteria but exceeded a 3 10gIO decrease
in inoculum (mean, 3.90 ± 0.44; range,3.32-4.54)after24
h with allantibiotics butrifampin (mean, 1.76). Growth curves
didnotdiffer fromlogarithmic-phase bacteria control curves.
The decrease in viability of tissuecagefluid bacteriawas
significantly (P = .028) slower thanthatof in vitrobacteria,
whether testedin logarithmic or in stationary phase; rifam-
pin, forwhich therewas tolerancein vitro,wasan exception.
Noneof the antimicrobial agents, on eitherS. aureus 120 or
MRGR3, led to a 3 10gIO decrease in initial inoculum after
24 h ofincubation (mean, 1.91 ± 0.80; range, 0.17 forrifam-
pin on S. aureus 120 to 2.48 for gentamicin). In the absence
of antibiotics, bacteriaassociated withthe foreign bodyalso
behaved differently fromin vitromicroorganisms, sincethere
wasa 2-hdelay for initiation ofpopulation growth (figure 1).
Bacteria directly detached from coverslips were studied with
oxacillin for S. aureus 120 and vancomycin for S. aureus
MRGR3. Therewas a strictparallelism between curves oftis-
suecagefluid andcoverslip bacteria,whetheror notexposed
to antibiotics (withoxacillin, decreasefrom5.31 ± 0.22 to
2.90 ± 0.36 10gIO cfu/ml after 24 h [difference, 2.41] for
cagefluid and from4.72 ± 0.90to 2.19 ± 0.27log10cfu/ml
[difference, 2.53] for coverslips).
Whentissuecagefluid bacteria werepreincubated in MHB
for 4 h before theyweretested, their kill curves and growth
kinetics werecomparable to thoseof batchculturebacteria.
Stationary-phase batchculture bacteria grown inbrothcon-
taining fibronectin didnotshow a significant alteration ofkill-
ing and growth patterns.
Discussion
Thisstudyfound a markedly decreased susceptibility ofS.
aureus associated with foreign body infection in vivoto the
killing effect of antibiotics when compared with batch cul-
turebacteria ofthesame straingrown underconventional con-
ditions. MBCs determined bytheclassical brothmacrodilution
method, which has been criticized [10], wereconfirmed by
an agar dilution technique and by kinetic studies.
Resistance of microorganisms to the killing actionof bac-
tericidal antimicrobial agents due to theirphysiologic condi-
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Figure 1. Killing kineticstudieson Staphylococcus aureus 120withfive antibiotics: oxacillin (4 I£g/ml), vancomycin, fleroxacin, gentami-
cin (8 I£g/ml each),andrifampin (2 I£g/ml). Bacteriagrownin vitroto logarithmic andstationary phasesweretestedas werethoserecovered
from tissue cage fluid. Mean and SD for three experiments for each condition are shown. Inoculaat time 0 were standardized to mean
inoculum value of all experiments (5.32 10gIO cfu/ml; SD, 0.17; range, 5.05-5.52).
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tionor to aparticularenvironment (phenotypic tolerance) has
been recognized since the early use of penicillin. In foreign
bodyinfections several determinants ofphenotypic tolerance
are likelyto be met. Slowgrowthis the most classiccondi-
tion that leadsto a decreasedsusceptibility ofbacteria to an-
tibioticsin fluids [11] andon surfaces[12]. It is thoughtlikely
thatbacteriaresponsible for infections withprosthetic devices
have low metabolic activity. In our experiments, there was
a 2-h lag time before the number of cage fluid bacteria in-
creased when bacteria were incubated in MHBwithout an-
tibiotic; this suggests possibledormancy thatdiffers fromthe
mere stationary phase of an overnight culture. When these
bacteriawereexposed to antibiotics in a growing phase,after
being in MHB for 4 h, their susceptibility to drugs was re-
stored. Nutrientlimitation[13] maybe implicated in thegen-
esis of resistance to killing in vivo.
A role for the biofilm (aggregates of microorganisms and
gross extracellular material)as a barrier againstthe penetra-
tion of antimicrobial agents has been suggested [14]. It ap-
pears this is not the unique component that determines the
resistanceofbacteriaassociatedwithforeign bodyinfections
to killing, since in our model, resistance was observed for
organisms in tissuecagefluidand for bacteriadetachedfrom
coverslips after disruptionof the biofilm. Thecoatingofbac-
teria by matrix proteins, such as fibronectin and fibrinogen,
could also havesome importance in vivo; however, incuba-
tion of batch culture bacteria in fibronectin in vitro did not
alter their susceptibility to killing.
Independent of these conditions, it is possiblethat surface
growthper se is in part responsible for tolerancedue to the
changes it induces in the ultrastructure of bacteria [15].
In conclusion, S. aureus recovered from an experimental
subcutaneous tissuecageinfection show a markedresistance
to the killingeffect of antimicrobial agents actingat different
bacterialsites. Thisphenomenon is likely to contribute to the
frequent failure of antibiotic therapy of infected implanted
devices. A systematic anddetailedstudyof thepathophysiol-
ogyofbacteriaassociated withforeign bodyinfections invitro
and in vivoshouldallowbetter understanding of the mecha-
nisms of this complex and important clinical problem.
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